| n= |
50 |
1925 |
|
| Mean Age at Diagnosis |
59.9 |
59.8 |
0.93 |
| Family History of PC, n= (%) |
13 (29.5) |
400 (24.6) |
0.38 |
| Clinical Gleason Score, n= (%) |
|
|
|
| Gl≤ 6 |
27 (61.4) |
1099 (65.6) |
0.43 |
| Gl = 7 |
12 (27.3) |
468 (27.9) |
|
| Gl≥ 8 |
5 (11.3) |
108 (6.5) |
|
| Clinical Stage ≤ T1c, n= (%) |
35 (79.6) |
1203 (72.0) |
0.31 |
| Pathologic Gleason Score, n= (%) |
|
|
|
| Gl≤ 6 |
19 (42.2) |
826 (50.7) |
0.10 |
| Gl = 7 |
20 (44.5) |
706 (43.3) |
|
| Gl≥ 8 |
6 (13.3) |
97 (6.0) |
|
| Pathologic Stage ≤ T2c, n= (%) |
31 (70.5) |
1301 (79.9) |
0.13 |
| Extracapsular Extension, n= (%) |
13 (28.9) |
306 (18.8) |
0.12 |
| Seminal Vesicle Invasion, n= (%) |
2 (4.4) |
86 (5.3) |
1.00 |
| Lymph Node Metastases, n= (%) |
0 |
16 (1.0) |
1.00 |
| Follow-up, months, median = (range) |
69.9 (0.2-180) |
55.5 (0-324) |
0.25 |
| Biochemical Recurrence, n= (%) |
6 (14.6) |
201 (12.7) |
0.64 |
